RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF
申请人:Aliagas Ignacio
公开号:US20120214811A1
公开(公告)日:2012-08-23
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
TANTAWY, ATIF, EGYPT. J. PHARM. SCI., 1983, 24, N 1-4, 307-312
作者:TANTAWY, ATIF
DOI:——
日期:——
[EN] RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS INHIBITEURS DES RAF KINASES ET LEURS PROCÉDÉS D'UTILISATION
申请人:GENENTECH INC
公开号:WO2011025965A1
公开(公告)日:2011-03-03
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers, tautomers, prodrugs and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed. [INSERT FORMULA I]